How to Finance an Independent Pharmacy Acquisition

A step-by-step look at buying a retiring pharmacist’s drug store with as little as 10% down, including how lenders value scripts, inventory, and goodwill.

Why Independent Pharmacies Are Lender-Friendly Acquisitions

Independent pharmacies sit in a rare category of small business: recurring, prescription-driven revenue with a customer base that refills on a predictable 30- or 90-day cycle. Lenders love that repeatability because it produces a cash-flow curve that looks far more like a subscription business than a retail store. When a retiring pharmacist puts a profitable store on the market, the underwriting question is less about whether revenue will show up and more about whether the buyer can hold the patient base together through the transition.

That predictability translates directly into leverage. A well-run independent doing $3M to $6M in annual revenue with 4% to 6% net margins can typically support acquisition debt at a purchase price of roughly 2.5x to 4x adjusted EBITDA, plus the wholesale value of on-hand inventory. Angel Funding Group’s mergers and acquisitions financing desk underwrites these deals on trailing twelve-month cash flow rather than hard collateral, which is what allows a pharmacist with strong credit but limited savings to buy a store outright.

The risk lenders actually price for is concentration. If a single long-term-care contract or one PBM network drives more than 30% of scripts, expect a tighter structure, a larger seller note, or a holdback tied to post-close script retention. Buyers who can document a diversified payer mix and a stable front-end retail contribution consistently get better terms.

Structuring the Deal With SBA 7(a) Debt

The SBA 7(a) program is the workhorse for pharmacy acquisitions because it finances goodwill, which conventional bank debt generally will not. Loans go up to $5 million, amortize over 10 years when no real estate is involved, and stretch to 25 years when the building is bundled into the same note. Rates are typically quoted as prime plus a spread, and there is no balloon, which keeps the monthly debt service predictable while you stabilize the store.

SBA rules require a 10% total equity injection on a change-of-ownership transaction. Critically, up to half of that can come from a seller note placed on full standby for the life of the loan, meaning a buyer may only need 5% in real cash. On a $2.4 million purchase, that is $120,000 of buyer equity plus a $120,000 standby seller note rather than $240,000 out of pocket. Structuring that seller note correctly, with the right standby language, is one of the highest-leverage things a broker does on your behalf.

Angel Funding Group routinely layers working capital into the same 7(a) facility. Rolling an extra $150,000 to $250,000 of post-close liquidity into the acquisition note is cheaper than raising it separately later, and it means you are not scrambling for cash the first month a wholesaler invoice and payroll land in the same week.

Valuing Scripts, Inventory, and Front-End Revenue

Most pharmacy valuations start with script count. A store filling 300 scripts per day at a healthy gross margin is a fundamentally different asset than one filling 90, even if revenue looks similar because of a few high-cost specialty drugs. Underwriters will pull a script-count trend for at least 24 months, because a store that has quietly lost 15% of its volume to a nearby chain will not support the same debt as one holding flat.

Inventory is the second component and it is usually purchased at cost through a physical count on the day of closing. A typical independent carries $200,000 to $500,000 in on-hand inventory, and because the exact figure is not known until the count, purchase agreements normally treat inventory as a separate line item on top of the business price. Make sure your loan is sized with headroom for that variance rather than assuming a fixed number.

Front-end retail, compounding, immunizations, and durable medical equipment all sweeten the deal because they diversify away from PBM reimbursement risk. If the store you are buying does meaningful compounding or has a growing vaccination program, document that revenue separately. It supports a higher valuation and it gives underwriters a reason to believe margins can be defended even if reimbursement rates tighten.

Getting to Close: Documents, Timeline, and Common Snags

Plan on 45 to 60 days from signed letter of intent to funding. Lenders will want three years of business tax returns and P&Ls, an interim year-to-date statement, a script count report from the dispensing system, an inventory estimate, the purchase agreement, your personal financial statement, and a resume showing pharmacy management experience. Assembling that package before you go to underwriting shaves two to three weeks off the calendar.

The most common delay is licensing. State board approval for a change of ownership, DEA registration, NCPDP number, and PBM network re-credentialing all move on their own timelines and can lag the loan approval by weeks. Experienced buyers start those applications the moment the LOI is signed rather than waiting for a loan commitment letter.

The second common snag is lease assignment. If the pharmacy rents its space, lenders need a landlord consent and typically a lease term at least as long as the loan, or the SBA will require a shorter amortization. Negotiate the lease extension during due diligence, not after your loan is conditionally approved.

Life After Close: Protecting Your Cash Position

The first 120 days after a pharmacy transfer are the tightest. You are paying wholesalers on their terms while PBM remittances for your first scripts are still clearing, and any interruption in payer credentialing stops cash from arriving even though prescriptions keep going out the door. A revolving business line of credit sized at roughly 30 to 45 days of drug spend is the standard buffer, and it costs nothing when it sits undrawn.

Watch script retention obsessively. Keep the retiring pharmacist visible in the store for 60 to 90 days as part of the transition agreement, keep the staff intact, and resist the urge to change the phone number, hours, or delivery routine. Patient relationships in an independent pharmacy live with the technicians as much as the pharmacist, so retention bonuses for key staff are money well spent.

Angel Funding Group can put the acquisition term debt, a working capital line, and merchant services for your front-end register on the table as one coordinated package. Getting all three sized at the same time keeps you from taking on expensive short-term money six months later because one piece was overlooked at close.